share_log

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Borgeson Blake

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Borgeson Blake

Recursion Pharmaceuticals | 4:持股變動聲明-董事 Borgeson Blake
美股sec公告 ·  06/27 19:18
Moomoo AI 已提取核心訊息
Blake Borgeson, a reporting person associated with Recursion Pharmaceuticals, Inc. [RXRX], completed a sale of 11,447 shares of Class A Common Stock on June 25, 2024. The transaction was executed in the open market at a price of $9.5052 per share, resulting in a total sale value of approximately $108,806. Following the sale, Borgeson directly holds a total of 7,177,116 shares in the company. The sale reflects a direct ownership transaction and was completed as an open market or private sale.
Blake Borgeson, a reporting person associated with Recursion Pharmaceuticals, Inc. [RXRX], completed a sale of 11,447 shares of Class A Common Stock on June 25, 2024. The transaction was executed in the open market at a price of $9.5052 per share, resulting in a total sale value of approximately $108,806. Following the sale, Borgeson directly holds a total of 7,177,116 shares in the company. The sale reflects a direct ownership transaction and was completed as an open market or private sale.
與Recursion Pharmaceuticals, Inc. [RXRX]有關的報告人Blake Borgeson於2024年6月25日完成了銷售11,447股A類普通股的交易。該交易在市場公開進行,每股價格爲9.5052美元,目前總銷售價值約爲108806美元。銷售後,Borgeson直接持有該公司7177116股,該銷售反映了直接所有權交易,並作爲市場公開或私人銷售完成。
與Recursion Pharmaceuticals, Inc. [RXRX]有關的報告人Blake Borgeson於2024年6月25日完成了銷售11,447股A類普通股的交易。該交易在市場公開進行,每股價格爲9.5052美元,目前總銷售價值約爲108806美元。銷售後,Borgeson直接持有該公司7177116股,該銷售反映了直接所有權交易,並作爲市場公開或私人銷售完成。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息